Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph E Tomaszewski

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 4, 2004
Multi-species toxicology approaches for oncology drugs: the US perspectiveJoseph E Tomaszewski
Biochemical Pharmacology|May 4, 2015
Proteasome inhibitorsBeverly A Teicher, Joseph E Tomaszewski
Current Cancer Drug Targets|October 8, 2003
Clinical development of 17-allylamino, 17-demethoxygeldanamycinEdward A Sausville, Joseph E Tomaszewski, Percy Ivy
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2005
Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37RvLee Jia, Lori Coward, Gregory S Gorman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 13, 2012
In vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damageHolger P Behrsing, Michael J Furniss, Myrtle Davis, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2009
In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell linesHolger Peter Behrsing, Michael J Furniss, Kristine A Robillard, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 31, 2005
Simultaneous estimation of pharmacokinetic properties in mice of three anti-tubercular ethambutol analogs obtained from combinatorial lead optimizationLee Jia, Joseph E Tomaszewski, Patricia E Noker, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2008
Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer TherapiesShivaani Kummar, James H Doroshow, Joseph E Tomaszewski, et al.
British Journal of Pharmacology|January 25, 2006
Interspecies pharmacokinetics and in vitro metabolism of SQ109Lee Jia, Patricia E Noker, Lori Coward, et al.
British Journal of Pharmacology|January 13, 2005
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drugLee Jia, Joseph E Tomaszewski, Colleen Hanrahan, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|May 4, 2004
Multi-species toxicology approaches for oncology drugs: the US perspectiveJoseph E Tomaszewski
Biochemical Pharmacology|May 4, 2015
Proteasome inhibitorsBeverly A Teicher, Joseph E Tomaszewski
Current Cancer Drug Targets|October 8, 2003
Clinical development of 17-allylamino, 17-demethoxygeldanamycinEdward A Sausville, Joseph E Tomaszewski, Percy Ivy
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2005
Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37RvLee Jia, Lori Coward, Gregory S Gorman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 13, 2012
In vitro exposure of precision-cut lung slices to 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole lysylamide dihydrochloride (NSC 710305, Phortress) increases inflammatory cytokine content and tissue damageHolger P Behrsing, Michael J Furniss, Myrtle Davis, et al.
Cancer Chemotherapy and Pharmacology|September 4, 2009
In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell linesHolger Peter Behrsing, Michael J Furniss, Kristine A Robillard, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 31, 2005
Simultaneous estimation of pharmacokinetic properties in mice of three anti-tubercular ethambutol analogs obtained from combinatorial lead optimizationLee Jia, Joseph E Tomaszewski, Patricia E Noker, et al.
European Journal of Cancer (Oxford, England : 1990)|December 19, 2008
Phase 0 clinical trials: recommendations from the Task Force on Methodology for the Development of Innovative Cancer TherapiesShivaani Kummar, James H Doroshow, Joseph E Tomaszewski, et al.
British Journal of Pharmacology|January 25, 2006
Interspecies pharmacokinetics and in vitro metabolism of SQ109Lee Jia, Patricia E Noker, Lori Coward, et al.
British Journal of Pharmacology|January 13, 2005
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drugLee Jia, Joseph E Tomaszewski, Colleen Hanrahan, et al.
Pageof 5